Amarin Corp Plc (AMRN)

[HDGabor]

i- (&MontanaState83 / 272747)

I keep going back to her description of "commercial success" ... "although Amarin barely turned a profit".. she's weighing market sucess and financial success against each other. … This ill conceived notion maybe the "smoking gun"

Man … cool down. Nothing to see here. Her determination of "Commercial success" is correct / fair. The conclusion ("the Court finds that Vascepa is a commercial success even though it has not yet turned a profit") should be read together with the discussion (abstract):

The parties also presented competing expert testimony on this topic at Trial. (ECF No. 369.) Having considered the expert testimony and other evidence presented by both sides, the Court finds Plaintiffs’ argument—that Vascepa is a commercial success—more persuasive.
More specifically, substantial and sustained increases in Vascepa prescriptions, net sales, and market share, as well as Vascepa’s positive net present value (“NPV”), demonstrate that Vascepa is a commercial success. (ECF No. 369 at 1423:3-15.) … Vascepa’s NPV also demonstrates its commercial success. NPV is the most common method that pharmaceutical companies use to determine whether to launch a new product and to track whether the product is successful. (Id. at 1440:1 15, 1444:22-1445:1, 1469:20-1470:7; see also Ex. 600 at 2, 5; Ex. 602 at 5.) A positive NPV means that the product is more profitable than the average for similar products in the industry. … Defendants’ contention that Vascepa is not a commercial success is largely based on the theory that Vascepa did not make a profit in its first six years on the market. But Defendants ignore the reality … Defendants’ alternative approach, which relies on taking a snapshot of Vascepa’s performance after Plaintiffs have incurred the vast majority of the R&D spending, but before they have enjoyed the fruits of that spending, is less persuasive in light of the testimony at Trial regarding industry practice. … In sum, the Court finds that Vascepa is a commercial success.

Best,
G